MedPath

CHULABHORN ROYAL ACADEMY

🇹🇭Thailand
Ownership
-
Established
2016-01-01
Employees
-
Market Cap
-
Website

Clinical Trials

36

Active:0
Completed:15

Trial Phases

4 Phases

Phase 1:3
Phase 2:14
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials

Phase 2
14 (66.7%)
Phase 1
3 (14.3%)
Not Applicable
2 (9.5%)
Phase 4
2 (9.5%)

Carotid Artery Stenosis and Ischemic Cerebrovascular Events After Radiotherapy in Patients With Head and Neck Cancer

Completed
Conditions
Carotid Artery Stenosis
Head and Neck Cancer
Radiation Therapy
Ischemic Stroke
Transient Ischemic Attack
First Posted Date
2024-08-16
Last Posted Date
2024-08-16
Lead Sponsor
Chulabhorn Royal Academy
Target Recruit Count
907
Registration Number
NCT06556979
Locations
🇹🇭

Department of Surgery, Chulabhorn Hospital, Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand, Bangkok, Thailand

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.